Erik Strömqvist

Erik Strömqvist

Director/Board Member bij STUDSVIK AB

54 jaar
Health Technology
Commercial Services
Electronic Technology

Profiel

Erik Strömqvist is currently the Chairman at MedTrace Pharma.
AS since 2024.
He is also an Independent Director at Studsvik AB since 2021.
In addition, he holds positions as a Director at Xvivo Perfusion AB, Celcibus AB, and Atley Solutions AB.
Furthermore, he serves as the Chief Operating Officer at Swiss Nuclides AG.
Previously, Mr. Strömqvist worked as a Director at Celcibus AB from 2020 to 2023.
He also held the position of President at Swiss Nuclides Sweden AB.
Prior to that, he was the General Manager-Cyclotrons & TRACERcenter at GE Healthcare AB from 2009 to 2020.

Actieve functies van Erik Strömqvist

BedrijvenFunctieBegin
STUDSVIK AB Director/Board Member 23-06-2021
XVIVO PERFUSION AB Director/Board Member -
Chief Operating Officer -
Director/Board Member 01-06-2021
Chairman 01-01-2024
Alle actieve functies van Erik Strömqvist

Eerdere bekende functies van Erik Strömqvist

BedrijvenFunctieEinde
Director/Board Member 01-06-2023
Corporate Officer/Principal 01-06-2020
Swiss Nuclides Sweden AB President -
Ervaring van Erik Strömqvist in detail bekijken

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Erik Strömqvist in detail bekijken

Connecties

44

Eerstegraads connecties

8

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
STUDSVIK AB

Commercial Services

XVIVO PERFUSION AB

Health Technology

Bedrijven in privébezit6

Health Technology

Health Technology

Commercial Services

Electronic Technology

Health Services

Swiss Nuclides Sweden AB

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Erik Strömqvist